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Introduction: Assistance provided to support people living with dementia and carers is 
highly valued by them. However, current support systems in Australia are disjointed, inac-
cessible to all, poorly coordinated, and focus on dysfunction rather than ability. Support 
workers for people with dementia are in short supply, and there is little consistency in 
their roles. To address this large service gap and unmet need, we have developed an 
evidence-based optimized model of holistic support for people with dementia and their 
carers and families. This article describes the “Support for Life” model intervention.
Methods: A stepped wedge cluster randomized controlled trial will be conducted over 
3 years across three Australian states. One hundred participants with dementia and/or 
their carers/family members will be randomly selected from community health center 
client lists in each state to receive either the dementia “Support for Life” intervention 
(Group A) or routine care (Group B). Group A participants will have access to the inter-
vention from year 1. Group B participants will continue to receive usual care and will 
not be denied information on dementia or dementia services in year 1. In year 2, Group 
B participants will have access to the intervention. A highly trained expert dementia 
support worker will provide the “Support for Life” intervention, which is a flexible, indi-
vidually tailored, holistic support that is relationship-centered, focused on enablement 
as opposed to dysfunction, and facilitate participants’ continued engagement in their 
community and the workforce. Additionally, dementia education, information resources, 
advocacy, and practical support to navigate and access dementia services and health 
care will be provided. The mode of support will include face to face, telephone, and 
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INtroDUctIoN: BAcKGroUND AND 
rAtIoNAlE
Models of support to assist people with dementia and their 
carers to adjust to living with memory loss, to navigate the 
health and aged care system, and to access services, informa-
tion, and support have recently been implemented both in 
Australia and overseas. However, there has been little high 
level evaluation of these services prior to a recent project that 
evaluated the effectiveness of the support worker role through a 
systematic review of international literature of support workers 
and models of support workers operating across Australia (1, 
2). This study was undertaken by members of the National 
Health and Medical Research Center (NHMRC) Cognitive 
Decline Partnership Center (CDPC) using a codesign approach 
involving consumers, industry partners, policy makers, and 
researchers to ensure a wide range of perspectives, including 
those of people with dementia, carer’s, and those working in 
the aged care industry (1, 2).
Findings from the CDPC project demonstrated that, although 
the dementia support worker role is highly valued, the current 
support system for people with dementia, their carers, and fami-
lies is based on a biomedical model, is disjointed, poorly coordi-
nated, and focuses on dysfunction and not on what people with 
dementia can still achieve. Additionally, no one service delivery 
model is accessible for people of all ages, diverse needs, or geo-
graphic locations. Our results also revealed insufficient numbers 
of support workers, support workers having high case loads that 
lead to them being time poor and experiencing burn out, and a 
lack of appropriate services available in the community to assist 
people with dementia and their families and carers to continue 
to undertake many of the regular activities of their daily life or 
actively engage in their community (2). Differences in available 
services were also dependent on the location of the service, such 
as the state in which the service was located and whether it was 
in a rural or metropolitan area (2). To address these gaps in 
services and the unmet needs of people with dementia and their 
carers and families, we have used the results from a systematic 
review of international models of support workers, an evaluation 
of Australian key worker models, and the perspectives of people 
with dementia and their carers to develop an optimized evidence-
based support model (1–3).
Our evidence-based optimized dementia support worker model 
“Support for Life” is underpinned by an overarching philosophy 
that incorporates the four key themes: relationship-centered, ena-
blement, holistic, and accessible. It articulates three components 
necessary to address current shortcomings: the necessary organi-
zational context in which dementia support workers are able to 
operate autonomously, the definition of the role and what activities 
a dementia support worker role undertakes, and the competencies 
that are required to carry out the role successfully (2).
As no previous Australian studies have demonstrated, high 
level evidence of the efficacy of a consumer-directed dementia 
support worker model that focuses on enablement and meeting 
the individual needs of people with dementia and their carers/
family members, we propose to test the efficacy of our optimized 
dementia support worker model by way of a cluster stepped 
wedge randomized controlled trial (4, 5).
This cluster stepped wedge randomized controlled trial 
will be the first Australian study to measure the efficacy and 
cost-effectiveness of the dementia support worker model. It is 
anticipated that this trial will provide high quality evidence of 
the efficacy and cost-effectiveness of a tailored, holistic, flexible, 
single service, and consistent approach to supporting people 
with dementia and their families and carers that promotes their 
well-being through the integration of services and health care, 
provision of emotional support, and enabling/encouraging them 
to remain actively engaged in the community.
Explanation for choice of comparators
The design was developed to combine the rigor of a cluster ran-
domized trial with the pragmatic approach of the stepped wedge 
design to implement the intervention at all sites (4–6).
objectives
To trial an optimized model, the “Support for life” program,  based 
on the findings from the NHMRC CDPC evaluation that investi-
gated the provision of support to people with dementia and their 
carers to address current shortcomings in support for people with 
dementia and their carers/families.
The “Support for Life” trial will be undertaken by a multidis-
ciplinary team with extensive track records in all key areas of the 
project. This team combines expertise in dementia knowledge, 
translation knowledge, provision of support, and delivery of 
internet interaction on an “as needed basis” for 12 months. The primary hypothesis is 
that the intervention will improve the quality of life of people with dementia and the health 
and well-being of carers/family through facilitating the continuation and enhancement 
of regular daily activities. Secondary hypotheses will examine other health and service 
usage outcomes. The outputs will also include a health economic analysis to investigate 
the costs (and savings) of any associated reduction in unnecessary health services use 
and delay in accessing permanent residential aged care.
trial registration number: Australian and New Zealand Clinical Trials Registry: 
ACTRN12616000927426p.
Keywords: dementia, carer support, quality of life, well-being, rct, protocol
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health services to people experiencing memory problems, cogni-
tive impairment, or dementia; and research methods including 
randomized controlled trials (RCTs). The team will also have 
access to expert health economic, policy and research design 
through the CDPC enabling subunits,  consumers and consumer 
representation through the Alzheimer’s Australia Consumer 
Dementia Research Network (CDRN) and statistical advice from 
the RDNS Institute statistician.
The “Support for Life” program is a whole of family approach 
to support that will assist people with dementia, their carers, 
and families to identify services that meet their individual need 
and offer them greater control and choice to continue to live and 
engage in life as fully as possible. This will help ensure that these 
services/supports include opportunities for people with dementia 
to have full access to “life activities” such as employment and 
recreation. Support will also focus on providing family members 
and/or carers the ability to actively participate in society and 
not be disadvantaged by their caring role. Active participation 
may mean continuing to work, attend school, university, and 
receiving appropriate support in these environments. To adhere 
to the overarching relationship-centered, enablement, holistic, 
and accessible principles that underpin the “Support for Life” 
program, workers providing support to people with dementia 
and their carers/families will
• require competencies in dementia knowledge, communication 
and interpersonal skills, the ability to generate ideas and prob-
lem solve, build and maintain relationships, and be empathetic 
and a good listener (1, 2).
• be enabled by a model of organizational support, which will 
ensure flexibility and autonomy, adequate resources, infra-
structure and personal support, quality assurance practices, 
and facilitate appropriate inter-professional and inter-sectoral 
collaboration (1, 2).
• have a clearly defined description of the role that incorporates 
the flexibility and autonomy to refer and link to services, assist 
with navigation of the service system, act as a point of contact 
and advocate, respond to individual needs, provide dementia- 
related education and information, provide practical and 
emotional support (1, 2).
Hypotheses
We hypothesize that connecting people with dementia and their 
families and carers to dementia support workers and volunteer 
mentors will lead to improvements in quality of life, reduce 
symptoms of depression, and facilitate the continuation of regular 
daily activities and enable community participation. The primary 
hypotheses are that involvement in the “Support for life” interven-
tion will
• improve the quality of life of people with dementia in the 
intervention group compared with the control group.
• improve the health and well-being of carers and/or family 
members in the intervention group compared with the control 
group.
The secondary hypotheses are that the involvement in the 
“Support for Life” intervention will
• reduce depression experienced by people with dementia in the 
intervention group compared with the control group.
• reduce the utilization of health-care resources by people with 
dementia in the intervention group compared with the control 
group.
• lead to an increase in uptake of support/respite services/
engagement in activities by people with dementia in the inter-
vention group compared with the control group.
• lead to a delay in accessing permanent residential aged care 
by people with dementia in the intervention group compared 
with the control group.
• reduce depression/psychological distress experienced by carers 
and/or family members in the intervention group compared 
with the control group.
trial Design
The evaluation of the “Support for Life” complex intervention will 
occur within a step-wedge cluster Randomized Controlled Trial 
(cRCT) involving multiple community health centers across three 
states over 3 years. Clusters are the community health centers, 
and approximately 10 centers in each state will participate in this 
study. Half of the centers (Group A) will be randomized to receive 
the intervention in year 1 and the other half in year 2 (Group B).
This “Support for Life” complex intervention proposes to trial a 
framework of a single service, highly flexible holistic approach to 
support for people with dementia and their families/carers. It will 
provide a platform to integrate current services and health care, 
provide emotional support, and enhance community and social 
engagement. Important principles are
• Protecting the person with dementia and their rights to 
full citizenship regardless of their age, gender, and cultural 
background.
• Providing access to support where there is diminished 
 decision-making capacity, retaining respect for the person 
with dementia but also the advocating for the rights of the 
family and caring unit.
• Improving access to palliation and “end of life care” in the 
setting of advanced or impaired decision-making, including 
with those who live alone.
This type of response builds on the strengths in a caring unit 
and addresses the needs of individual relationships. In line with 
“codesign” and “consumer directed care” (CDC) principles, 
the person with dementia, their family, and other members of 
the caring unit will actively design/influence what this service 
response will look like. Ongoing evaluation will allow for flex-
ibility and change.
MEtHoDs: PArtIcIPANts, 
INtErVENtIoNs, AND oUtcoMEs
study setting
Community/Primary/Ambulatory Care
Collaborations with Primary Health Networks (PHNs) in 
Victoria, New South Wales, and Queensland will be used to 
assist with the identification of community health centers from 
FIGUrE 1 | “support for life” stepped wedge cluster randomized control trial (sWcrct) study design. Overall, there are 30 clusters participating, 
10 clusters in each state, and so the above figure shows the design that is replicated in each state. In each cluster, we aim to recruit 10 study participants having 
dementia or cognitive impairment, making the overall recruitment target at 300 participants. Data are collected from all participants during the seven data collection 
time points shown by a dashed-line in the above figure (i.e., at baseline and 3, 6, 12, 15, 18, and 24 months). We expect an attrition rate of 20 percent; therefore, 
we expect approximately 240 participants with dementia or cognitive impairment and approximately 1,680 participant data points to be examined in this SWcRCT. 
Attrition is expected to occur at any time point, and the modeling will include all participant data; participant data may be complete (available from all seven time 
points) or incomplete (available from one to six time points). The intensive intervention phase is shown in dark blue. The post-intervention phase is shown in 
light-blue (this is the second year for the year 1 intervention group), where participants can still access the intervention, but the intervention will no longer be 
promoted at those clusters.
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metropolitan and regional areas, have a high incidence of patients 
with dementia, and diverse populations (including CALD and 
LGBTI).
Eligibility criteria
Criteria for inclusion will include people who are experiencing 
memory problems, cognitive decline, or having a formal diagnosis 
of dementia who are living in the community setting and willing 
to provide written, informed consent to participate in the study. 
People who are unable to self-manage but who have a carer will 
not be excluded from the study. Carers and family members of a 
person who is experiencing memory problems, cognitive decline, 
or dementia and are willing to provide written, informed consent 
are also eligible for participation in the study. The exclusion 
criteria include consumers who are already receiving a support 
intervention or have acute psychosis.
Intervention
Dementia Support Workers, recruited from each of the three 
states, will inform the Community Health Centers of our trial 
of the provision of dementia friendly support to their patients by 
assisting them in getting the right services and the right people 
at the right place.
Group A participants will be from Group A cluster sites and 
will have access to the “Support for Life” intervention from year 
1. This “Support for Life” complex intervention proposes to trial 
a framework of a single service, highly flexible holistic approach 
to support for people with dementia and their families/carers. It 
will provide a platform to integrate current services and health 
care, provide emotional support, and enhance community and 
social engagement by
• Working with the “person with dementia or cognitive impair-
ment and those who support them” regardless of age, gender, 
and cultural background.
• Focusing on strengths of the people involved in order to main-
tain and improve physical and emotional health and well-being.
• Planning for the future to provide peace of mind.
• Use of an assistant and volunteers to help identify/create/facil-
itate access to services and enhance the social engagement of 
people with dementia or their carers and families in response 
to their stated goals or needs.
• Recognizing the challenges for young people and children and 
actively prototyping within the setting of their situation. It will 
require age appropriate responses and support mechanisms.
Group B participants will continue to receive usual care by 
health service providers and will not be denied information on 
dementia or dementia services in year 1. In year 2, Group B 
participants will have access to the “Support for Life” interven-
tion making this a step-wedge study design. In year 2, Group 
A participants, who receive the intervention in year 1, may still 
access the intervention, but the intervention will no longer be 
actively promoted at those sites. See Figure 1 for the trial design.
outcomes
Primary outcomes (baseline, 3, 6, 12, 15, 18, and 24 months)
Person with dementia
• Improvement in quality of life (suitable for use by people 
with moderate to severe levels of dementia) (QOL-AD) (7)
Carer/family members
• Improvement in well-being of carer/family unit [Carer 
experience scale (CES)] (8, 9)
Secondary outcomes (baseline, 6, 12, 18, and 24 months)
Person with dementia
• Reduction in symptoms of depression (GDS 15) (10)
• Increased attendance at social activities/services (staff/
family/carer report/interviews)
tABlE 1 | outcome measures.
Baseline 3 months 6 months 12 months 15 months 18 months 24 months
Primary outcomes
Person with dementia: improvement in quality 
of life
QOL-AD QOL-AD QOL-AD QOL-AD QOL-AD QOL-AD QOL-AD
Carer/family members: improvement in 
well-being
CES CES CES CES CES CES CES
secondary outcomes
Person with dementia: reduced symptoms of 
depression
GDS 15 GDS 15 GDS 15 GDS 15
Person with dementia: increase in social  
activities
Interview/
client records
Interview/ 
client records
Interview/ 
client records
Interview/ 
client records
Interview/
client records
Person with dementia: increase in social 
engagement
Interview/
client records
Interview/ 
client records
Interview/ 
client records
Interview/ 
client records
Interview/
client records
Person with dementia: change in health service 
utilization
RUD RUD RUD RUD RUD
Person with dementia: delay in accessing 
permanent residential aged care services
Interview/client 
records
Interview/ 
client records
Interview/ 
client records
Interview/ 
client records
Interview/
client records
Carer/family members: reduction in depression/
psychological distress
GHQ-12 GHQ-12 GHQ-12 GHQ-12
Carer/family members: increase in social 
engagement/ability to continue regular activities
Interview/client 
records
Interview/client 
records
Interview/client 
records
Interview/ 
client records
Interview/
client records
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• Increased engagement in social activities/services/ability 
to continue to participate in regular activities (staff/family/
carer report/interviews)
• Change in health-care service utilization [client records/
resource utilization in dementia (RUD) (11) health records]
• Delay in accessing permanent residential aged care services 
(client records/interviews)
Carer/family members
• Reduction in carer depression/psychological distress 
[General Health Questionnaire-12 (GHQ-12)] (12)
• Increase in social engagement and ability to continue regu-
lar activities (self report/interviews).
(See Table 1 for a full list of instruments).
EcoNoMIc MEtHoDoloGY 
AND ANAlYsIs
• Utility measured by EQ-5D-5L (13)
• Reduction in health service utilization measured by RUD and 
administrative data
• Reduced carer time (paid and unpaid) measured by RUD
• Delay in permanent admission to residential care.
schedule of Events
At baseline, we will administer the primary and secondary meas-
ures to all participants. At 3, 6, 12, 15, 18, and 24 months, we will 
administer the primary measures. At 6, 12, 18, and 24 months, 
we also administer the secondary measures. All participants will 
follow this schedule of data collection regardless of group alloca-
tion. See Figure 1.
The intensive intervention phase at each cluster is shown in 
Figure  1. During this phase, the intervention will be actively 
promoted at the indicated clusters. The post-intervention phase 
is shown in light-blue, where participants can still access the 
intervention, but the intervention will no longer be actively 
promoted at those clusters.
sample size
The study is powered to detect small–medium effects in the pri-
mary outcome measures of QOL-AD for people with dementia or 
cognitive impairment (0.23 effect size) and in the CES for carers 
(0.25 effect size).
The sample size required is 30 clusters with 10 participants/
families in each to allow for an attrition of 20%. This is a total of 
100 participant/families (50 in each group) in each of the 3 states, 
making a total sample size of 300. This will detect significant 
differences in caregiver’s and people with dementia or cognitive 
impairment’s quality of life between two groups at effect sizes 
of 0.23–0.25 (small–medium effects). Sample size calculations 
were completed using STATA statistical software stepped wedge: 
for clusters defined at the level of the community health center, 
power of 0.80, significance level set at 0.05, intraclass correlation 
coefficient (ICC) of 0.05, the number of steps (2), participant 
data collected at seven time points (baseline, 3, 6, 12, 15, 18, and 
24 months), and primary outcome distributions as described in 
existing literature, i.e., QOL-AD scores between 15 and 60 and 
SD of 7 (6, 7, 14, 15) and CES scores between 0 and 100 and SD 
of 10 (8, 9).
recruitment
Participants with dementia or cognitive impairment and their 
carers/family members will be randomly assigned from com-
munity health center client lists and then randomly allocated 
to receive either the dementia “Support for Life” program 
(Group  A, n =  50 per state) or routine care only (Group B, 
n = 50 per state).
6Goeman et al. Support for Life RCT Protocol
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We will apply quota sampling so that clusters comprise of 
essentially similar participants. Ten participants from each cluster 
are required, and so recruitment will cease within the following 
subgroups at each cluster when the following characteristics are 
attained:
 – Age
 ⚬ Five participants are aged <65 years
 ⚬ Five participants are aged >65 years
 – Gender
 ⚬ Five females
 ⚬ Five males
 – Diversity/cultural background
 ⚬ Eight born in Australia
 ⚬ Two from CALD/LGBTI communities
MEtHoDs: AssIGNMENt 
oF INtErVENtIoNs 
(For coNtrollED trIAls)
randomization
Clusters are community health centers participating in the study. 
Randomization of clusters to an intervention year (1 or 2) will be 
done using a minimization routine balancing numbers in groups 
as randomization proceeds (16). To guard against confounding 
by major differences in clusters, randomization will be strati-
fied by state (Victoria, New South Wales, or Queensland), area 
(metropolitan or regional), and socioeconomic status of area that 
cluster is located within [defined by 1–3 versus 4–5 quintile of the 
area index of relative disadvantage (IRSD)].
Allocation
Sequence Generation
Participants with dementia or cognitive impairment and their 
carers/family members will be randomly selected from com-
munity health center client lists and then randomly selected to 
receive either the dementia “Support for Life” program (Group A, 
n = 50 per state) or routine care only (Group B, n = 50 per state).
Allocation Concealment Mechanism
Computer generated randomization of Group A and Group B 
will be performed by an independent researcher after the baseline 
data are collected.
Implementation
The allocation sequence will be developed by a statistician 
blinded to the study details. Identified potential participants will 
be approached, recruited, and enrolled by experienced members 
of the research team in each state. The statistician who generates 
the allocation sequence mentioned above will pass this code to 
the overseer of the recruitment process.
Blinding (Masking)
The Research Officer undertaking the data collection will be 
blinded to participant group allocation. Participants (people 
living with dementia or cognitive impairment in the community, 
carers of people with dementia or cognitive impairment living in 
the community, and family members of people with dementia or 
cognitive impairment living in the community) will be blinded to 
their group allocation.
MEtHoDs: DAtA collEctIoN, 
MANAGEMENt, AND ANAlYsIs
Primary and secondary data collection will occur at baseline and 3, 
6, 12, 15, 18, and 24 months post-randomization (Figure 1). This 
will involve a face to face visit with a researcher. Participants will 
receive a telephone call and an information letter with study ques-
tions 10 to 14 days prior to the baseline and all follow-up visits. The 
telephone contact will be used to arrange a mutually suitable time 
and location for the face to face visit as well as provide informa-
tion to participants about what will take place at the forthcoming 
visit. Participants will have the option to complete questionnaires 
prior to the visit or complete them during the researchers visit. 
Interviews will take place during the face to face visit and will 
be audio-taped prior to transcription and importation into the 
NVivo Qualitative Software to aid analysis. The researcher will 
be trained in quantitative and qualitative data collection methods 
and any relevant outcome measure assessments. They will also be 
experienced in communicating with people with dementia and 
their carers and families including collecting data from partici-
pant and proxy (carer/family member) when necessary.
Inter-rater reliability
To ensure consistency of the interpretation/coding of the qualita-
tive interview data and the measurement of the quantitative 
data, we will calculate the correlation between the ratings of two 
researchers. Data coded into the statistical software will also be 
checked to ensure its accuracy.
Data Management
All hard copy and audio-recorded data will be kept confidential 
and stored in a locked filing cabinet in the research group office 
and in softcopy in a password protected database according to 
ethical storage and disposal of data as stated in the NHMRC 
guidelines. Data will be only accessible to the chief investigator 
research officer, project manager, and statistician. The research 
team will monitor the integrity of the trial data. All participant 
data will be entered into an appropriate database such as Redcap 
(https://projectredcap.org/) or the Statistical Package for Social 
Sciences (SPSS) package and screened to detect any errors. 
A range of checks will be undertaken prior to data analysis.
The project manager will be employed to oversee the project 
and to manage the project data from each of the three states, 
including data cleaning and data merging.
statistical Methods
Data Analysis Plan
Quantitative Analysis
Primary Analyses. We will use all data along with the original 
designated group allocation and an intention to treat approach 
as the primary analytic framework. Descriptive data on both 
groups will be reported including demographics, stratification 
variables, baseline measures, and number of times intervention 
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Frontiers in Public Health | www.frontiersin.org October 2016 | Volume 4 | Article 245
was accessed. Descriptive statistics will be used to summarize 
the characteristics of all participants including carers and family 
members. Deterioration of the primary outcome measure in indi-
viduals due to increasing dementia severity/aging and occurring 
over the 2-year data collection period will be explored using mul-
tivariate analyses (including factors: intervention status, age, and 
gender). If the dementia severity/aging factor is found to be sig-
nificant, it will be included in the main models described below.
A linear mixed effects model will be used to compare the 
intervention and usual care periods for continuous outcomes and 
generalized linear mixed effects model for binary outcomes. The 
model will include intervention status and time as fixed effects 
and cluster site and individuals as random effects. Where appro-
priate, cluster and individual factors strongly correlated with the 
outcome will also be included as fixed effects in the model. These 
may include the stratification variables, e.g., socioeconomic 
status of area. The estimated intervention effect will be reported 
as the mean outcome difference for continuous outcomes and 
odds ratio for binary outcomes between intervention and control 
periods, assuming a constant treatment effect over time. The 
estimated intervention effects will be reported with 95% CIs 
and p-values. The analysis will investigate an interaction effect 
between intervention and time.
Missing Data
The analysis method chosen will use all available data. Every effort 
will be made to minimize missing outcome data at each wave, 
and reasons individuals are lost to follow-up will be recorded. A 
missing data analysis will seek to identify systematic patterns of 
missing data and identify instances where, despite the efforts of 
the research team, data may be missing not at random (MNAR). 
Whether or not data are identified as MNAR, for each primary 
outcome and other key variables with missing data, multiple 
imputation using multivariate regression with factors of age, 
gender, state, and time will produce 100 estimates for each miss-
ing item – supporting optimal statistical estimation. Sensitivity 
analyses will be conducted to assess the robustness of the missing 
data assumption made in the primary analysis. A detailed analysis 
plan will be developed for secondary and sensitivity analyses.
Qualitative Analysis
Interview transcripts and journal entries will be managed using 
QSR NVivo (Qualitative Solutions and Research, Melbourne, 
Victoria). Interview data will be initially coded into broad topic 
areas using content analysis, and then constant comparative 
method will be applied to develop theoretical insights.
Economic Analysis
Resource Use
The cost of the delivery of the program will be calculated using 
actual wage rates, and resources used for each participant 
subtracting any resources used specifically for the purposes 
of research. Health-care resource use will be costed for each 
participant using administrative data or data collected using the 
RUD instrument by multiplying use by appropriate unit costs 
sourced from government databases. These include Medicare 
for items such as GP and specialist visits, PBS for medications, 
and National Hospital Cost data reports for hospital and ED 
presentations. Community care will be costed using administra-
tive data from the RDNS. Costs over 12 months will be compared 
between groups using a generalized linear model, which is able 
to account for the non-normal distribution of cost data. Cost of 
carer time will be accounted for using a proxy good method (17) 
to recognize the value of unpaid caregiving duties. Costs will be 
reported by sector (health, community, and type of participant) 
in order to understand the implications of the intervention to 
different interest groups and sectors.
oUtcoMEs
The primary outcome for the economic analysis is the quality 
adjusted life years (QALYs). Utility values will be derived from 
the CES, and EQ-5D-5L will be used to construct QALYs over 
12  months using an area under the curve analysis. QALYs for 
both the carer and the participant will be combined for use in a 
cost–utility analysis. Research is currently underway to develop 
an algorithm for estimating utility values from the QOL-AD (CI 
Comans), and if an algorithm is available, QALYs will also be 
estimated from this instrument and compared with the values 
obtained from the generic EQ-5D-5L instrument.
Cost and QALYs will be combined into an Incremental Cost-
effectiveness ratio (ICER). The analysis will be over 12 months to 
match the trial duration and will take a limited societal perspec-
tive in order to incorporate the costs and outcomes of the carers 
and participants as well as the health-care costs and outcomes. 
Uncertainty in the cost–utility results will be estimated using 
non-parametric bootstrapping techniques and represented as 
cost-effectiveness acceptability curves.
MEtHoDs: MoNItorING FIDElItY 
oF tHE INtErVENtIoN/ADHErENcE 
to tHE Protocol
An advisory and data monitoring committee (ADMC) will be 
established for the study and a protocol prepared to provide guid-
ance to the study research team. The role of the ADMC will be to 
advise investigators in regard to implementation, maintenance, 
and monitoring of the overall conduct of the trial; safeguard the 
interests of study participants; and assess the intervention to 
ensure any potential adverse events are averted. Membership of 
the advisory committee will include a geriatrician, senior clini-
cal nurse advisor dementia, state government representatives, 
consumer advocacy groups, and consumers.
Audits to monitor the fidelity of the intervention and adher-
ence to the protocol will be undertaken on a six monthly basis.
EtHIcs AND DIssEMINAtIoN
The Support for Life study involves working with participants 
who are living with memory loss or dementia and their carers and 
families. To ensure that the needs of these participants are met, 
the research team includes investigators with expert knowledge 
in dementia and aged care services.
Approval to conduct the study has been applied for from the 
RDNS Human Research Ethics Committee in Victoria and will 
also be sought from The University of Sydney Human Research 
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Ethics Committee in New South Wales and the Queensland 
University of Technology Human Research Ethics Committee in 
Queensland. All participants will be provided with detailed writ-
ten information and have an opportunity to discuss participation 
before providing written or verbal consent. Verbal consent will be 
audio-taped. Participants will be advised that they can withdraw 
from the study at any point.
Any required modifications to the study protocol, such as 
changes to eligibility criteria, outcomes, and analyses, will be dis-
cussed by the study investigators and after agreement is reached 
will be submitted to the abovementioned Ethics committees for 
approval. Amendments describing any modifications to the study 
protocol will also be made to the relevant trials registry.
confidentiality
Personal information about potential and enrolled participants 
will be collected and then de-identified prior to it being shared 
to ensure confidentiality of participants is maintained before, 
during, and after the trial. Only the project manager, research 
team, and dementia support worker will have access to the final 
trial dataset.
Declaration of Interests
The study investigators declare that they have no conflicts of 
interest.
Access to Data
Only investigators and approved researchers added by ethics 
approval will have access to the final trial data set.
Ancillary and Post trial care
The intervention has been developed by a lead service provider 
and a research team with expertise in dementia care, dementia 
research, and interventions for people with dementia, it is believed 
that the need to discontinue the intervention will be extremely 
minimal. If any participant becomes distressed as a result of 
participation in our trial, they will be referred to appropriate 
counseling support services.
Dissemination Policy
Results from the trial will be provided to study participants and 
disseminated to health-care professionals through presentation 
at seminars, conferences, and publication in scientific journals 
and relevant media. Guidelines for authorship will be adhered to.
Appendices
Informed Consent Materials
Model consent form and other related documentation will be 
given to participants and authorized surrogates.
strENGtHs AND lIMItAtIoNs 
oF tHIs stUDY
• This study is the first to implement a stepped wedge cluster 
randomized controlled trial (SWCRCT) design to provide 
high quality evidence of the efficacy and cost-effectiveness 
of a tailored, holistic, flexible, single service, and consistent 
model that promotes the well-being of people with cognitive 
impairment or dementia, their carers, and their family and 
enables/encourages them to remain actively engaged in the 
community.
• A major strength is that the development of the intervention 
development used high quality evidence gained from a sys-
tematic review of international models of support workers; an 
evaluation of Australian key worker models; and a codesign 
approach with people with dementia and aged care industry 
partners, policy makers, and researchers.
• With the stepped wedge design, all clusters will ultimately 
receive the intervention, while those waiting for the interven-
tion to commence act as controls.
• The stepped wedge design means that some clusters wait 
for up to 12  months before starting the intervention, which 
may increase dropout rates and decrease motivation for 
participation.
• The stepped wedge design will overcome the logistical con-
straint of not being able to deliver the intervention concur-
rently to all clusters.
• Using a stepped wedge design will also enable all participating 
clusters to ultimately receive the “Support for Life” interven-
tion, which is an advantage when working with a vulnerable 
population group where it is not ethical to withhold an inter-
vention that is perceived to be beneficial.
AUtHor coNtrIBUtIoNs
SKO and DG conceived the study. The CDPC Activity 3, 4, 
and 17 research teams, working group, and reference group 
members contributed to the development and refinement 
of the proposal in conjunction with DG, SKO, ER, SK, and 
EB. JE led the calculation of the sample size and quantitative 
components of the protocol, and TC led the economic evalu-
ation components. DG drafted the protocol paper, and all the 
authors contributed to the draft and approved the final version 
of the paper.
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